Robert J. Gould
2020 - Fulcrum Therapeutics
In 2020, Robert J. Gould earned a total compensation of $3M as President and Chief Executive Officer at Fulcrum Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Bonus | $240,750 |
|---|---|
| Option Awards | $2,240,600 |
| Salary | $535,000 |
| Total | $3,016,350 |
Gould received $2.2M in option awards, accounting for 74% of the total pay in 2020.
Gould also received $240.8K in bonus and $535K in salary.
Rankings
In 2020, Robert J. Gould's compensation ranked 3,829th out of 13,090 executives tracked by ExecPay. In other words, Gould earned more than 70.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,829 out of 13,090 | 71st |
Division Manufacturing | 1,524 out of 5,621 | 73rd |
Major group Chemicals And Allied Products | 575 out of 2,254 | 75th |
Industry group Drugs | 495 out of 1,954 | 75th |
Industry Pharmaceutical Preparations | 374 out of 1,459 | 74th |
Source: SEC filing on April 29, 2021.
Gould's colleagues
We found two more compensation records of executives who worked with Robert J. Gould at Fulcrum Therapeutics in 2020.